CCL5 (RANTES), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CCL5 (RANTES), Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CCL5 (RANTES), Human |
| Clone | REA346 |
| Host Species | Recombinant Human |
| Reactive Species | human, nonhuman primate |
| Isotype | IgG1 |
| Format | allophycocyanin (APC) conjugate |
| Size | 30 tests in 300 µL |
| Concentration | 1:10 |
| Applications | Intracellular flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CCL5 (RANTES) Antibody, anti-human, APC, REAfinity™. Clone REA346 recognizes the human C-C motif chemokine 5 (CCL5) antigen, a 8 kDa protein also known as RANTES (regulated on activation, normal T cell expressed and secreted). CCL5 belongs to the C-C chemokine family and is a target gene of NF-κB activity. It is expressed by T lymphocytes, macrophages, platelets, synovial fibroblasts, tubular epithelium, and certain types of tumor cells. NF-κB activation by different stimuli such as CD40L or interleukin 15 (IL-15) induces CCL5 production. CCL5 plays an active role in recruiting a variety of leukocytes into inflammatory sites including T cells, macrophages, eosinophils, and basophils. In collaboration with certain cytokines that are released by T cells such as IL-2 and interferon γ (IFN-γ), CCL5 also induces the activation and proliferation of particular natural killer cells to generate C-C chemokine-activated killer cells. CCL5 produced by CD8+ T cells and other immune cells has been shown to inhibit HIV entry into target cells. CCL5 activity is mediated through its binding to CCR1, CCR3, and mainly CCR5. CCR4 and CD44 are auxiliary receptors for CCL5. | Additional information: Clone REA346 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | C-C motif chemokine 5, SCYA5, SIS-delta, SISd, TCP228, EoCP, T-cell-specific protein RANTES, RANTES |
| Gene, Accession # | Gene ID: 6352 |
| Catalog # | 130-105-494 |
| Price | $142 |
| Order / More Info | CCL5 (RANTES), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Schall, T. J. et al. (1988) A human T cell-specific molecule is a member of a new gene family. J Immunol 141 (3): 1018-1025. | Capoulade-Metay, C. et al. (2006) A natural CCL5/RANTES variant antagonist for CCR1 and CCR3. Immunogenetics 58 (7): 533-541. | Long, H. et al. (2012) Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-κB-mediated MMP-9 up regulation. Stem Cells 30 (10): 2309-2319. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies